NEW YORK (GenomeWeb) – IDbyDNA announced today that it has raised $9 million in a Series A financing round.

The University of Utah spinout company said it will use the funds to launch metagenomics-based clinical tests for infectious diseases, and to further develop DNA search technologies based on the Taxonomer metagenomics analysis platform for universal pathogen detection and host-response profiling it co-developed with the University of Utah and ARUP Laboratories.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.